Integris Medtech IPO GMP
Integris Medtech IPO is a Mainboard book-built issue comprising a fresh issue of up to ₹600 crore and an Offer for Sale of up to 1,08,37,266 equity shares by Evercure Holdings Pte. Ltd. The IPO is expected to open on November 27, 2026, and close on Decemb
Integris Medtech IPO GMP Today
Day-wise grey market premium. Est. listing = price cap + GMP.
GMP history will appear here once grey-market activity begins.
Integris Medtech IPO Details
See the full Integris Medtech IPO details & review →
What is Integris Medtech IPO GMP?
Integris Medtech IPO GMP refers to the unofficial premium or discount at which the IPO shares may reportedly trade in the grey market before listing. It is not an official price or a guaranteed indication of the listing price.
What is the Current Integris Medtech IPO GMP?
The current GMP is not available. Grey market information may become available closer to the IPO opening date, but it should be treated as unofficial market data.
What is the Price Band of Integris Medtech IPO?
The price band has not yet been announced. The final price band will be disclosed by the company before the IPO bidding period.
What is the Expected Listing Date of Integris Medtech IPO?
The shares are expected to list on BSE and NSE on December 4, 2026, subject to the final IPO timetable.
Does Integris Medtech IPO GMP Guarantee Listing Gains?
No. GMP does not guarantee listing gains or the actual listing price. The final listing price depends on market demand, company fundamentals, valuation and broader market conditions.